Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research40

Loading search results…

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research40

FiltersClear all

Status

Recruiting17
Enrolling by invitation1
Active, not recruiting9
Completed10
Terminated3

Study type

Interventional40
Observational8
Not on ClinicalTrials.gov66

Phase

Not applicable32
Phase 34
Phase 12
Phase 22

Investigator

Brian DeRubertis6
Mehraneh Dorna Jafari6
David M. Otterburn3
Peter Connolly3
Benjamin Samstein3

Department

Surgery40
Medicine750
Pediatrics81
Neurology46
Psychiatry46

Show all 22Show fewer

Condition

Chronic Limb-Threatening Ischemia7
Aortic Aneurysm, Thoracoabdominal2
Blood Loss, Surgical2
Colorectal Neoplasms2
Crohn Disease2

Intervention type

Device26
Drug8
Procedure7
Other5
Biological3
Diagnostic test1

Sponsor type

Industry28
WCM (investigator-initiated)10
Other academic2

Start date

Has results posted6

Interventional×Surgery×Clear all

Showing 1–20 of 40 studiesSort:

Active, not recruitingInterventional · Not applicableNCT04090424 ↗
A Pivotal Study to Assess the Safety and Effectiveness of NovoSorb® Biodegradable Temporizing Matrix (BTM) in the Treatment of Severe Burn Skin Injuries

FiltersClear all

Status

Recruiting17
Enrolling by invitation1
Active, not recruiting9
Completed10
Terminated3

Study type

Interventional40
Observational8
Not on ClinicalTrials.gov66

Phase

Not applicable32
Phase 34
Phase 12
Phase 22

Investigator

Brian DeRubertis6
Mehraneh Dorna Jafari6
David M. Otterburn3
Peter Connolly3
Benjamin Samstein3

Department

Surgery40
Medicine750
Pediatrics81
Neurology46
Psychiatry46

Show all 22Show fewer

Condition

Chronic Limb-Threatening Ischemia7
Aortic Aneurysm, Thoracoabdominal2
Blood Loss, Surgical2
Colorectal Neoplasms2
Crohn Disease2

Intervention type

Device26
Drug8
Procedure7
Other5
Biological3
Diagnostic test1

Sponsor type

Industry28
WCM (investigator-initiated)10
Other academic2

Start date

Has results posted6

Interventional×Surgery×Clear all

Showing 1–20 of 40 studiesSort:

Active, not recruitingInterventional · Not applicableNCT04090424 ↗
A Pivotal Study to Assess the Safety and Effectiveness of NovoSorb® Biodegradable Temporizing Matrix (BTM) in the Treatment of Severe Burn Skin Injuries

Show all 22

Show fewer

Cheguevara Afaneh2
Kelly A Garrett2
Rajesh Kumar Malik2
Christopher Agrusa1
Dustin Joseph Carpenter1
Fabrizio Michelassi1
James J. Gallagher1
Jeffrey W Milsom1
Lea Channah Lowenfeld1
Philip Hyungjin Chang1
Rasa Zarnegar1
Rajeev Dayal1
Rebecca J Craig-Schapiro1
Robert J. Winchell1
Sandip Kapur1
Steven Chao1
Thomas J Fahey1

Obstetrics and Gynecology41

Radiology36

Radiation Oncology28

Dermatology20

Neurological Surgery19

Cardiothoracic Surgery17

Urology15

Rehabilitation Medicine13

Population Health Sciences9

Otolaryngology Head and Neck Surgery7

Pathology and Laboratory Medicine1

Pharmacology1

Show all 32

Show fewer

Liver Diseases2
Peripheral Arterial Disease2
Anastomotic Leak1
Aortic Aneurysm, Abdominal1
Breast Neoplasms1
Burns1
Colonic Neoplasms1
Delayed Graft Function1
Diverticulitis1
Encopresis1
Fecal Incontinence1
Feeding Behavior1
Gallbladder Diseases1
Gastrointestinal Diseases1
Goiter1
Hernia, Hiatal1
Infections1
Inflammation1
Intestinal Diseases1
Pain1
Pneumoperitoneum1
Postthrombotic Syndrome1
Rectal Diseases1
Rectal Fistula1
Thyroid Nodule1
Venous Thromboembolism1
Venous Thrombosis1

Dietary supplement1

Philip Hyungjin ChangPI

Intervention: Device: NovoSorb BTM · Procedure: Standard of Care
Dates: Sep 2021 – May 2026 (est.)
Sponsor: PolyNovo Biomaterials Pty. Ltd

Burns

Active, not recruitingInterventional · Not applicableNCT04095663 ↗

Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) Trial

Steven ChaoPIMehraneh Dorna JafariPI

Intervention: Procedure: Partial Colectomy · Other: Medical Management
Dates: Oct 2019 – Feb 2027 (est.)
Sponsor: University of Washington, The

Diverticulitis

Active, not recruitingInterventional · Phase 1NCT04190862 ↗

An Open-Label, Single-Center, Investigator Initiated Phase 1B Trial of E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

Jeffrey W MilsomPI

Intervention: Drug: E-CEL UVEC
Dates: Jan 2020 – Dec 2026 (est.)
Sponsor: Weill Medical College of Cornell University

Anal Fistula

Active, not recruitingInterventional · Not applicableNCT04227899 ↗

LIFE-BTK (pivotaL Investigation of saFety and Efficacy of BRS Treatment-Below The Knee) Randomized Controlled Trial

Peter ConnollyPI

Intervention: Device: Esprit BTK Device · Device: Percutaneous Transluminal Angioplasty (PTA) Device
Dates: Aug 2020 – Aug 2023· Results posted
Sponsor: Abbott Cardiovascular Systems, Inc.

Critical Limb Ischemia (CLI)

RecruitingInterventional · Not applicableNCT04891510 ↗

A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery

David M. OtterburnPI

Intervention: Device: REVOLVE Advanced Adipose System · Device: LipoGrafter · Procedure: Viality
Dates: May 2021 – Jun 2028 (est.)
Sponsor: Weill Medical College of Cornell University

MastectomyMammaplastyBreast Reconstruction

RecruitingInterventional · Not applicableNCT05190978 ↗

Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction

David M. OtterburnPI

Intervention: Device: Acellular Dermal Matrix · Procedure: Reconstruction without ADM
Dates: Oct 2022 – Apr 2027 (est.)
Sponsor: University of California, Los Angeles

Breast CancerBreast ImplantComplications, Infection or Inflammation

RecruitingInterventional · Not applicableNCT05313165 ↗

Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial

Brian DeRubertisPI

Intervention: Device: LimFlow Stent Graft System
Dates: Dec 2022 – May 2027 (est.)
Sponsor: LimFlow, Inc.

Critical Limb IschemiaChronic Limb-Threatening IschemiaPeripheral Arterial Disease

RecruitingInterventional · Not applicableNCT05701917 ↗

DEFIANCE - ClotTriever® Thrombectomy System vs. Anticoagulation Alone for Treatment of Deep Vein Thrombosis

Rajesh Kumar MalikPI

Intervention: Device: ClotTriever System · Drug: Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc.
Dates: Jan 2023 – Jan 2028 (est.)
Sponsor: Inari Medical

Venous ThromboembolismDeep Venous ThrombosisPost-Thrombotic Syndrome

Active, not recruitingInterventional · Phase 3NCT05776277 ↗

A Two-stage, Randomized, Controlled Trial Comparing the Safety and Efficacy of Iltamiocel With Placebo in the Treatment of Female Participants With Chronic Fecal Incontinence and a History of Obstetric Anal Sphincter Injury (DigniFI)

Kelly A GarrettPI

Intervention: Biological: Iltamiocel · Other: Placebo
Dates: Mar 2024 – Dec 2026 (est.)
Sponsor: Cook MyoSite, Inc.

Fecal Incontinence

RecruitingInterventional · Not applicableNCT06071429 ↗

Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease

Brian DeRubertisPI

Intervention: Device: MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold · Device: Percutaneous Transluminal Angioplasty (PTA)
Dates: Apr 2025 – Mar 2028 (est.)
Sponsor: R3 VASCULAR INC

Chronic Limb-Threatening Ischemia

RecruitingInterventional · Not applicableNCT06182397 ↗

MAGICAL BTK: Randomized Controlled Trial of MAGIcTouch - Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease

Brian DeRubertisPI

Intervention: Device: MagicTouch PTA Sirolimus drug coated balloon · Device: Placebo balloon angioplasty
Dates: Jan 2025 – Dec 2026 (est.)
Sponsor: Concept Medical Inc.

Arterial Disease of LegsBelow-the-knee ObstructionPAD - Peripheral Arterial Disease

Enrolling by invitationInterventional · Not applicableNCT06311773 ↗

Pivotal Multicenter Trial of the Boomerang® Catheter for Percutaneous Deep Vein Arterialization (pDVA)

Brian DeRubertisPI

Intervention: Device: Boomerang Catheter
Dates: Apr 2024 – Mar 2027 (est.)
Sponsor: Aveera Medical, Inc.

Chronic Limb-Threatening Ischemia

RecruitingInterventional · Not applicableNCT06434194 ↗

Serranator OCT: Understanding the Mechanism of Action of Serration Angioplasty by Serranator Versus Conventional Balloon Angioplasty for below-the Knee (BTK) Artery Disease Using Optical Coherence Tomography (OCT)

Brian DeRubertisPI

Intervention: Device: Serranator PTA Serration Catheter · Drug: PTA (Standard of Care)
Dates: Oct 2024 – Jun 2025 (est.)
Sponsor: Cagent Vascular, LLC

Critical Limb Ischemia

RecruitingInterventional · Not applicableNCT06444347 ↗

The Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair in Robotic Anti-Reflux Surgery: A Multi-Institutional Randomized Trial

Rasa ZarnegarPI

Intervention: Device: Biosynthetic Mesh · Procedure: Hiatal Hernia Repair
Dates: Jun 2024 – Jul 2027 (est.)
Sponsor: Weill Medical College of Cornell University

Hiatal Hernia

RecruitingInterventional · Phase 1NCT06456073 ↗

An Open-Label, Single-Center, Investigator Initiated Phase 1B Trial of E-CEL UVEC Cell Therapy for the Treatment of Chronic Anal Fissure

Kelly A GarrettPI

Intervention: Biological: E-CEL UVEC cells (AB-207)
Dates: Sep 2024 – Dec 2026 (est.)
Sponsor: Weill Medical College of Cornell University

Chronic Anal Fissure

RecruitingInterventional · Not applicableNCT06556654 ↗

Evaluation of the Safety and Effectiveness of the GORE® Tissue Reinforcement for Breast Reconstruction Device (TRBR Device) When Used in the Reinforcement of Breast Reconstruction

David M. OtterburnPI

Intervention: Device: TRBR Device
Dates: Apr 2025 – Jul 2027 (est.)
Sponsor: W.L. Gore & Associates, Inc.

Breast Reconstruction Surgery

Active, not recruitingInterventional · Not applicableNCT06578741 ↗

GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study

Peter ConnollyPI

Intervention: Device: GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device)
Dates: Nov 2024 – Jun 2027 (est.)
Sponsor: W.L. Gore & Associates, Inc.

Abdominal Aortic AneurysmPararenal Aortic AneurysmThoracoabdominal Aortic Aneurysm

Active, not recruitingInterventional · Not applicableNCT06656364 ↗

Esprit BTK Post-Approval Study (Esprit BTK PAS)

Brian DeRubertisPI

Intervention: Device: Esprit BTK System
Dates: Oct 2024 – Apr 2027 (est.)
Sponsor: Abbott Laboratories, Inc.

Chronic Limb-Threatening Ischemia

RecruitingInterventional · Not applicableNCT06717308 ↗

Surgical Drape With an Atraumatic Acrylic Adhesive for Negative Pressure Wound Therapy

Robert J. WinchellPI

Intervention: Device: Comfort Release® NPWT drape
Dates: Feb 2025 – Feb 2027 (est.)
Sponsor: Global BioMedical Technologies LLC

Frequency and Type of Medical Adhesive-Related Skin InjuryNPWT Drape Seal Effectiveness Rate (or Leak Incidence Rate)Clinician Acceptability of New NPWT Drape+2 more

Active, not recruitingInterventional · Phase 2NCT06744647 ↗

A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of ALXN2030 in Adult Patients With Antibody-Mediated Rejection After Kidney Transplantation

Rebecca J Craig-SchapiroPI

Intervention: Drug: ALXN2030 · Drug: Placebo
Dates: Mar 2025 – Oct 2027 (est.)
Sponsor: Alexion Pharmaceuticals, Inc.

Antibody-Mediated RejectionKidney TransplantationBiopsy-proven Histologic Scores+1 more

‹ Prev1 2 Next ›